Gregorio
Rabago Juan Aracil
Consultor Médico
Ana
Alfonso Piérola
Investigadora Consultora
Publikationen, an denen er mitarbeitet Ana Alfonso Piérola (2)
2017
-
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study
European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43